Decentralized Clinical Trials: Considerations for Implementation
Decentralized clinical trials (DCTs) have been defined as patient-centric studies executed through telemedicine and mobile/local healthcare providers using processes and technologies differing from the traditional clinical trial model.4 DCTs were designed to augment or replace traditional in-clinic approaches with direct-to-patient (DTP) and data-driven alternatives, with an emphasis on in-home care that offered access to larger patient populations and reduced trial costs. They offer a strategy for technology-enhanced clinical trials that are more accessible to patients by moving clinical trial activities to a wider variety of settings, including telehealth and remote patient monitoring options.
